Alternatives
Alternatives to Gadoteridol 4189.5 mg/15 mL injection
1 other presentations of Gadoteridol 4189.5 mg/15 mL injection
There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Gadoteridol), strength (4189.5 mg/15 mL) and dosage form (injection) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Gadoteridol 4189.5 mg/15 mL injectionThis pageIntravenous | — | US FDA | 5 vials of 15 mL | DO NOT FREEZE. Should freezing occur in the vial, Gadoteridol Injection, USP should be brought to room temperature before use. Store at 20° to 25°C (68° to77° F). Excursions permitted to 15°C to 30°C (59°F to 86°F). If allowed to stand at room temperature for a minimum of 60 minutes, Gadoteridol Injection, USP should return to a clear, colorless to slightly yellow solution. Protect from light. | On request | — | Available on request |
| ProHance 4189.5 mg/15 mL injectionIntravenous | Bracco Diagnostics | US FDA | 5 vials of 15 mL | DO NOT FREEZE. Should freezing occur in the vial, ProHance should be brought to room temperature before use. Store at 25°C (77° F). Excursions permitted to 15°C to 30°C (59°F to 86°F). If allowed to stand at room temperature for a minimum of 60 minutes, ProHance should return to a clear, colorless to slightly yellow solution. Protect from light. | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Gadoteridol 4189.5 mg/15 mL injectionNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.